PALISADE BIO, INC.PALIEarnings & Financial Report
Nasdaq
PALI Q3 2025 Key Financial Metrics
Revenue
$0
Gross Profit
N/A
Operating Profit
$-2.9M
Net Profit
$-2.9M
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
YoY Growth
N/A
EPS
$-0.38
PALISADE BIO, INC. Q3 2025 Financial Summary
PALISADE BIO, INC. reported revenue of $0 for Q3 2025, with a net profit of $-2.9M (N/A margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $0 |
|---|---|
| Net Profit | $-2.9M |
| Gross Margin | N/A |
| Operating Margin | N/A |
| Report Period | Q3 2025 |
PALISADE BIO, INC. Annual Revenue by Year
PALISADE BIO, INC. annual revenue history includes year-by-year totals (for example, 2024 revenue was $0).
| Year | Annual Revenue |
|---|---|
| 2024 | $0 |
| 2023 | $250.0K |
| 2022 | $0 |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $14.1M | $12.7M | $12.9M | $9.3M | $10.9M | $8.2M | $6.7M | $7.0M |
| Liabilities | $2.7M | $2.6M | $2.9M | $2.7M | $3.4M | $2.9M | $4.0M | $3.8M |
| Equity | $11.3M | $10.1M | $9.9M | $6.6M | $7.5M | $5.3M | $2.6M | $3.2M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-2.7M | $-3.2M | $-3.5M | $-3.1M | $-2.4M | $-2.3M | $-1.8M | $-3.6M |